4I1.F Stock Analysis
4I
Avoid
Based on Eyestock quantitative analysis, 4I1.F`s fundamental data and valuation indicate an investment grade of Avoid at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Greatly overvalued
Philip Morris International, Inc. is a holding company engaged in the manufacturing and sale of cigarettes, tobacco, and nicotine-containing products. The company is headquartered in Stamford, Connecticut and currently employs 79,800 full-time employees. The company went IPO on 2008-03-17. The company focuses on delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. Its product portfolio consists of cigarettes and smoke-free products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company is engaged in developing smoke-free products for adults along with building scientific assessment capabilities in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. The United States Food and Drug Administration (FDA) has authorized versions of its IQOS Platform 1 device and consumables, and Swedish Match's General snus, as Modified Risk Tobacco Products (MRTPs). Its portfolio consists of both international and local brands and is led by Marlboro. Its other cigarette brands include Chesterfield, L&M and Philip Morris.